Letter

Phytoestrogens and menopause

BMJ 2002; 324 doi: 10.1136/bmj.324.7328.52 (Published 5 January 2002)
Cite this as: BMJ 2002;324:52.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Published evidence supports a role for phytoestrogens in menopause

  1. Alan J Husband, research director
  1. Novogen Limited, 140 Wicks Road, North Ryde, New South Wales 2113, Australia
  2. Systemic Therapy Program, British Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia, Canada V5Z 4E6

    EDITOR—In her editorial on phytoestrogen therapy for menopausal symptoms Davis has overlooked published information that would have argued against claims that there is no good evidence that isoflavone phytoestrogens are any better than placebo.1 In fact, good published evidence shows that they are effective not only for managing acute symptoms of the menopause but also for improving cardiovascular and bone health.

    According to Davis, the published data cited showed that an over the counter tablet preparation of isoflavones extracted from red clover had no greater benefit than placebo for vasomotor symptoms.2 Although it is correct that in this study …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular